NASDAQ$MDLN
Medline Inc · Q4 2025 earnings
Q4 2025 earnings · · Before market open
Briefing
Medline reported Q4 2025, revenue of $7.80B, net income of $180M.
For Q4 2025, Medline reported revenue of $7.80B, net income of $180M per the quarterly earnings release and SEC filing.
- Revenue $7.80B.
- Net income $180M.
- Medline discussed capital allocation and operating priorities.
Headline financials
Revenue & EPS history
Medline Inc · Revenue · Quarterly
$7.8B
Forward guidance
Medline outlook reflects management commentary on growth, costs, and capital in the filing.
Tailwinds
- Liquidity and balance sheet discussed.
- Core operating trends in MD&A.
Headwinds
- Macro and competitive pressure.
- One-time items may affect comparability.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 2 quarterly earnings reports · overlaid with Q4 2025
-5.5%
Avg return
Earnings day
-10.8%
Avg return
5 days after
-21.6%
Avg return
30 days after
0%
0 / 2 earnings
Positive
-3.6%
Q4 2025
Best reaction
-7.3%
Q1 2026
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | -7.3% | -13.4% | -25.9% | |
| Q4 2025 | -3.6% | -8.3% | -17.3% |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro